Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of biologically active compounds by combining 3D QSAR and structure-based design methods.

Wolfgang Sippl1

  • 1Institute for Pharmaceutical Chemistry, Heinrich-Heine-Universität Düsseldorf, D-40225 Düsseldorf, Germany. sippl@pharm.uni-duesseldorf.de

Journal of Computer-Aided Molecular Design
|June 27, 2003
PubMed
Summary

Accurate prediction of biomolecule binding affinity is crucial for drug design. This study developed an automated receptor-based 3D-QSAR method, combining docking and GRID/GOLPE, to create predictive models for drug targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis, Biological Evaluation, and Molecular Docking Studies of 2r,3t,4c-Configured C-Furanosidic LpxC Inhibitors.

Archiv der Pharmazie·2026
Same author

Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia.

Leukemia·2026
Same author

Functional divergence and structural changes of Class IV histone deacetylases (HDACs) across the tree of life.

Molecular biology and evolution·2026
Same author

Covalent drugs reimagined: from cysteine-targeted inhibitors to proteome-informed precision therapeutics.

Bioorganic chemistry·2026
Same author

Dual FLT3/MAPK14 Proteolysis-Targeting Chimera (PROTAC) Induces Potent Acute Myeloid Leukemia Cell Death.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Advances in SIRT2-Targeted Therapeutics: Structural Insights, Chemical Strategies, and Degrader Technologies.

Medicinal research reviews·2026

Area of Science:

  • Computational chemistry
  • Drug discovery and design
  • Molecular modeling

Background:

  • Predicting binding affinity is a key challenge in computational drug design.
  • Accurate models are needed for novel biomolecules and drug targets.

Purpose of the Study:

  • To develop and test an automated receptor-based 3D-QSAR methodology.
  • To apply this method to drug targets like estrogen receptor, acetylcholine esterase, and protein-tyrosine-phosphatase 1B.

Main Methods:

  • Combined molecular docking (AutoDock) with 3D-QSAR.
  • Utilized GRID interaction fields and the GRID/GOLPE approach for comparative field analysis.
  • Validated ligand alignments against X-ray crystallographic data.

Main Results:

Related Experiment Videos

  • Generated highly predictive 3D-QSAR models.
  • Demonstrated the effectiveness of the automated procedure across multiple drug targets.
  • Achieved accurate molecular alignments using docking.

Conclusions:

  • Receptor-based 3D-QSAR is a valuable tool for drug design.
  • The developed methodology can analyze high-throughput and virtual screening data.
  • This approach enhances the prediction of binding affinity for novel compounds.